Arbutus Biopharma Corporation (ABUS)

Last Closing Price: 4.07 (2026-11-19)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arbutus Biopharma Corporation (ABUS) had Net Income of $59.12M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.30M
Net Income
$59.12M
--
$0.30M
$10.79M
$-10.49M
$69.61M
$59.12M
$59.12M
--
--
--
--
$-10.49M
$-10.48M
198.68M
199.63M
$0.30
$0.30
Balance Sheet Financials
$339.57M
--
$0.13M
$339.70M
$241.93M
--
$12.02M
$253.95M
$85.75M
$85.75M
$85.75M
199.28M
Cash Flow Statement Financials
$225.68M
$1.04M
$19.47M
$18.01M
$264.19M
$246.18M
$4.17M
--
--
Fundamental Metrics & Ratios
1.40
--
--
--
--
100.00%
-3509.70%
-3509.70%
--
19770.90%
19770.90%
$225.68M
--
--
--
0.00
--
0.38
238.39
--
--
--
--
$0.43
$1.13
$1.13